Serologic Tests for Threadworm Infection Compared for Accuracy
By LabMedica International staff writers Posted on 10 Feb 2014 |
Image: Larva of the nematode parasite Strongyloides stercoralis (Photo courtesy of Centers of Disease Control and Prevention).
The diagnosis of Strongyloides stercoralis or threadworm infection is hampered by the suboptimal sensitivity of fecal-based tests.
There are several serological methods that are believed to be more sensitive than microscopy, although assessing their accuracy is difficult because of the lack of sensitivity of a fecal-based reference gold standard.
Microbiologists at the Sacro Cuore Hospital (Negra Verona, Italy) and their colleagues assessed the sensitivity and specificity of five serologic tests for S. stercoralis, three in-house and two commercially available, on 399 cryopreserved serum samples. Accuracy was measured using fecal results as the primary reference standard, but also using a composite reference standard based on a combination of tests.
The primary reference standard was direct detection of S. stercoralis larvae in stool, either through microscopy of at least three fecal samples after formol-ether concentration or Baermann, or stool agar/charcoal culture for S. stercoralis. Index serologic tests included three noncommercial tests: immunofluorescence antibody test (IFAT), recombinant Strongyloides antigen (NIE) enzyme-linked immunosorbent assay (NIE-ELISA) and the NIE- luciferase immunoprecipitation systems (NIE-LIPS). The two commercially available tests were the Bordier ELISA (Bordier Affinity Products; Crissier, Switzerland) and the SeroELISA Strongyloides IgG (IVD-ELISA) (IVD Research; Carlsbad, CA, USA).
The most sensitive test was IFAT, with 94.6% sensitivity, followed by IVD-ELISA with 92.3% sensitivity. The most specific test was NIE-LIPS, with specificity at 99.6%, followed by IVD-ELISA at 97.4%. NIE-LIPS did not cross-react with any of the specimens from subjects with other parasitic infections. NIE-LIPS and the two commercial ELISAs approach 100% specificity at a cut off level that maintains equal to or greater than 70% sensitivity.
The authors concluded that NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection. IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies, and inclusion in clinical trials. IFAT loses sensitivity when gaining specificity at the optimal cut off for inclusion with a titer 1/160. The two commercially available ELISA tests showed reliable results in terms of accuracy and can also be used for inclusion in trials. The study was published on January 9, 2014, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Sacro Cuore Hospital
Bordier Affinity Products
IVD Research
There are several serological methods that are believed to be more sensitive than microscopy, although assessing their accuracy is difficult because of the lack of sensitivity of a fecal-based reference gold standard.
Microbiologists at the Sacro Cuore Hospital (Negra Verona, Italy) and their colleagues assessed the sensitivity and specificity of five serologic tests for S. stercoralis, three in-house and two commercially available, on 399 cryopreserved serum samples. Accuracy was measured using fecal results as the primary reference standard, but also using a composite reference standard based on a combination of tests.
The primary reference standard was direct detection of S. stercoralis larvae in stool, either through microscopy of at least three fecal samples after formol-ether concentration or Baermann, or stool agar/charcoal culture for S. stercoralis. Index serologic tests included three noncommercial tests: immunofluorescence antibody test (IFAT), recombinant Strongyloides antigen (NIE) enzyme-linked immunosorbent assay (NIE-ELISA) and the NIE- luciferase immunoprecipitation systems (NIE-LIPS). The two commercially available tests were the Bordier ELISA (Bordier Affinity Products; Crissier, Switzerland) and the SeroELISA Strongyloides IgG (IVD-ELISA) (IVD Research; Carlsbad, CA, USA).
The most sensitive test was IFAT, with 94.6% sensitivity, followed by IVD-ELISA with 92.3% sensitivity. The most specific test was NIE-LIPS, with specificity at 99.6%, followed by IVD-ELISA at 97.4%. NIE-LIPS did not cross-react with any of the specimens from subjects with other parasitic infections. NIE-LIPS and the two commercial ELISAs approach 100% specificity at a cut off level that maintains equal to or greater than 70% sensitivity.
The authors concluded that NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection. IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies, and inclusion in clinical trials. IFAT loses sensitivity when gaining specificity at the optimal cut off for inclusion with a titer 1/160. The two commercially available ELISA tests showed reliable results in terms of accuracy and can also be used for inclusion in trials. The study was published on January 9, 2014, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Sacro Cuore Hospital
Bordier Affinity Products
IVD Research
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms